Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revue D'Epidemiologie Et De Sante Publique|December 24, 2011
[Impact of socioeconomic status on stage at diagnosis of breast cancer]F Berger, A Doussau, C Gautier, et al.
La Revue De Medecine Interne|April 4, 2006
[Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database]A Doussau de Bazignan, F Thiessard, G Miremont-Salamé, et al.
Bulletin Du Cancer|January 12, 2011
[Dose finding methods for targeted agents: new perspectives]X Paoletti, S Postel-Vinay, V Servois, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsA Doussau, R Thiébaut, B Geoerger, et al.
Radiation Oncology (London, England)|August 14, 2015
French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsV Vendrely, B Henriques de Figueiredo, E Rio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
The Journal of Frailty & Aging|April 20, 2016
Design of a Physical Activity Program to Prevent Functional Decline in Onco-Geriatric Patients (CAPADOGE): A Randomized Multicenter TrialJ Durrieu, A Doussau, A Rieger, et al.
The French Journal of Urology|February 1, 2026
Risk Factors for RNA Integrity in Fresh-Frozen Renal Cancer Samples from Routine Practice (UroCCR 9)G Margue, G Capon, B C Niort, et al.
The British Journal of Dermatology|October 9, 2012
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trialS Prey, K Ezzedine, A Doussau, et al.
Pageof 2